Biosig Technologies Inc (BSGM)

[iamnottheone]

very nice land and more news was out today: SeeThruEquity Issues Update on BioSig Technologies, Inc. (OTCQB: BSGM) Highlighting Enhanced Relationship with Mayo Clinic
NEW YORK, NY / ACCESSWIRE / March 24, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update note on BioSig Technologies, Inc. (BSGM).

The report is available here: BSGM March 2016 Update Note. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

"In our opinion, it appears that BioSig's relationship with the Mayo Clinic - a prestigious industry partner - is strong and deepening. Earlier this month, for example, Ammar Killu, MBBS of the Mayo Clinic in Rochester, presented pre-clinical data from a series of studies at the Mayo Clinic during 2015 at the 13th International Dead Sea Symposium on Innovations in Cardiac Arrhythmias and Device Therapy at the David Intercontinental Convention Center in Tel Aviv. The presentation was entitled Enhanced Electrophysiology Recording Improves Signal Acquisition and Differentiation and featured work done utilizing Pure EP™ technology in work done in pre-clinical studies by Dr. Samuel Asirvatham and his team. BioSig has indicated that it expects at least one Mayo study to be published in a high profile medical journal during 1H16E, which we reason has the potential to attract the attention of both investors and industry leaders," stated Ajay Tandon, CEO of SeeThruEquity. "We are maintaining our 12-month price target of $3.53 per share."
http://finance.yahoo.com/news/seethruequity-issues-biosig-technologies-inc-132800360.html